Loading…
Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease
The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons ha...
Saved in:
Published in: | Scientific reports 2016-10, Vol.6 (1), p.35203-35203, Article 35203 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3 |
container_end_page | 35203 |
container_issue | 1 |
container_start_page | 35203 |
container_title | Scientific reports |
container_volume | 6 |
creator | Viereckel, Thomas Dumas, Sylvie Smith-Anttila, Casey J. A. Vlcek, Bianca Bimpisidis, Zisis Lagerström, Malin C. Konradsson-Geuken, Åsa Wallén-Mackenzie, Åsa |
description | The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which
NeuroD6
and
Grp
were expressed within different dopaminergic subpopulations of the VTA, and
TrpV1
within a small heterogeneous population. Optogenetics-coupled
in vivo
amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by
TrpV1-Cre
-expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders. |
doi_str_mv | 10.1038/srep35203 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_uu_307529</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835508737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</originalsourceid><addsrcrecordid>eNplks9u1DAQxiMEolXpgRdAlrgAYsGO7Ti5IFW7sFTqQiX-XC3HmWxdEjvYCaveeAdOvB5PwqBdVlvwxZbm529mPn1Z9pDRF4zy8mWKMHCZU34nO86pkLOc5_ndg_dRdprSNcUj80qw6n52lCtV5JxVx9mPlWvqaJwnS_BAPtgI4J1fk_MG_OhaB4kY8g42ZAUpGGunvjYdWXbTaHozQlw7Sy7NeLUxN8T4BuGViV8gkjZEsgiD6R3qzqHrEspMMQwxjGBHaAg2vUTW-RT8r-8_E1m4BCbBg-xea7oEp7v7JPv05vXH-dvZxfvl-fzsYmaFkuNMNQKktVWBi9Si5pWoweYNtIIqC7KltqxyUbatqKvCGsGlUMIwqJvCFCUHfpI93-qmDQxTrYfoehNvdDBOL9znMx3iWk-T5lShc4i_2uLI9tBY9Cea7tav2xXvrvQ6fNOSKlaWBQo82QnE8HWCNOreJYvOGA9hSpqVXEpaKq4QffwPeh2m6NENpKqKMSpVidTTLWVjSJiDdj8Mo_pPOPQ-HMg-Opx-T_6NAgLPdm5gya8hHrT8T-0356LHRg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899110578</pqid></control><display><type>article</type><title>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Viereckel, Thomas ; Dumas, Sylvie ; Smith-Anttila, Casey J. A. ; Vlcek, Bianca ; Bimpisidis, Zisis ; Lagerström, Malin C. ; Konradsson-Geuken, Åsa ; Wallén-Mackenzie, Åsa</creator><creatorcontrib>Viereckel, Thomas ; Dumas, Sylvie ; Smith-Anttila, Casey J. A. ; Vlcek, Bianca ; Bimpisidis, Zisis ; Lagerström, Malin C. ; Konradsson-Geuken, Åsa ; Wallén-Mackenzie, Åsa</creatorcontrib><description>The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which
NeuroD6
and
Grp
were expressed within different dopaminergic subpopulations of the VTA, and
TrpV1
within a small heterogeneous population. Optogenetics-coupled
in vivo
amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by
TrpV1-Cre
-expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep35203</identifier><identifier>PMID: 27762319</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38/61 ; 45/77 ; 631/378/340 ; 631/378/3920 ; 64/110 ; 64/60 ; 9/10 ; 9/74 ; Addictions ; Amperometry ; Animals ; Basic Helix-Loop-Helix Transcription Factors - genetics ; Basic Helix-Loop-Helix Transcription Factors - metabolism ; Capsaicin receptors ; Dopamine ; Dopamine - metabolism ; Dopamine receptors ; Dopaminergic Neurons - metabolism ; Dopaminergic Neurons - pathology ; GABAergic Neurons - metabolism ; GABAergic Neurons - pathology ; gamma-Aminobutyric Acid - metabolism ; Gastrin-Releasing Peptide - genetics ; Gastrin-Releasing Peptide - metabolism ; Gene expression ; Gene Expression Regulation ; Genetics ; Glutamatergic transmission ; Glutamic Acid - metabolism ; Heterogeneity ; Humanities and Social Sciences ; Humans ; Information processing ; Mental disorders ; Mesencephalon ; Mice ; Mice, Transgenic ; Mood ; Movement disorders ; multidisciplinary ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - metabolism ; Neurodegenerative diseases ; Neurological diseases ; Neurons ; Optics ; Optogenetics ; Parkinson Disease - genetics ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Parkinson's disease ; Pars Compacta - metabolism ; Pars Compacta - pathology ; Rodents ; Schizophrenia ; Science ; Subpopulations ; Substantia nigra ; Synaptic Transmission ; TRPV Cation Channels - genetics ; TRPV Cation Channels - metabolism ; Ventral Tegmental Area - metabolism ; Ventral Tegmental Area - pathology ; Ventral tegmentum ; γ-Aminobutyric acid</subject><ispartof>Scientific reports, 2016-10, Vol.6 (1), p.35203-35203, Article 35203</ispartof><rights>The Author(s) 2016</rights><rights>Copyright Nature Publishing Group Oct 2016</rights><rights>Copyright © 2016, The Author(s) 2016 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</citedby><cites>FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1899110578/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1899110578?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27762319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-307529$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Viereckel, Thomas</creatorcontrib><creatorcontrib>Dumas, Sylvie</creatorcontrib><creatorcontrib>Smith-Anttila, Casey J. A.</creatorcontrib><creatorcontrib>Vlcek, Bianca</creatorcontrib><creatorcontrib>Bimpisidis, Zisis</creatorcontrib><creatorcontrib>Lagerström, Malin C.</creatorcontrib><creatorcontrib>Konradsson-Geuken, Åsa</creatorcontrib><creatorcontrib>Wallén-Mackenzie, Åsa</creatorcontrib><title>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which
NeuroD6
and
Grp
were expressed within different dopaminergic subpopulations of the VTA, and
TrpV1
within a small heterogeneous population. Optogenetics-coupled
in vivo
amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by
TrpV1-Cre
-expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.</description><subject>38/61</subject><subject>45/77</subject><subject>631/378/340</subject><subject>631/378/3920</subject><subject>64/110</subject><subject>64/60</subject><subject>9/10</subject><subject>9/74</subject><subject>Addictions</subject><subject>Amperometry</subject><subject>Animals</subject><subject>Basic Helix-Loop-Helix Transcription Factors - genetics</subject><subject>Basic Helix-Loop-Helix Transcription Factors - metabolism</subject><subject>Capsaicin receptors</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>Dopamine receptors</subject><subject>Dopaminergic Neurons - metabolism</subject><subject>Dopaminergic Neurons - pathology</subject><subject>GABAergic Neurons - metabolism</subject><subject>GABAergic Neurons - pathology</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>Gastrin-Releasing Peptide - genetics</subject><subject>Gastrin-Releasing Peptide - metabolism</subject><subject>Gene expression</subject><subject>Gene Expression Regulation</subject><subject>Genetics</subject><subject>Glutamatergic transmission</subject><subject>Glutamic Acid - metabolism</subject><subject>Heterogeneity</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Information processing</subject><subject>Mental disorders</subject><subject>Mesencephalon</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mood</subject><subject>Movement disorders</subject><subject>multidisciplinary</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Neurodegenerative diseases</subject><subject>Neurological diseases</subject><subject>Neurons</subject><subject>Optics</subject><subject>Optogenetics</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson's disease</subject><subject>Pars Compacta - metabolism</subject><subject>Pars Compacta - pathology</subject><subject>Rodents</subject><subject>Schizophrenia</subject><subject>Science</subject><subject>Subpopulations</subject><subject>Substantia nigra</subject><subject>Synaptic Transmission</subject><subject>TRPV Cation Channels - genetics</subject><subject>TRPV Cation Channels - metabolism</subject><subject>Ventral Tegmental Area - metabolism</subject><subject>Ventral Tegmental Area - pathology</subject><subject>Ventral tegmentum</subject><subject>γ-Aminobutyric acid</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNplks9u1DAQxiMEolXpgRdAlrgAYsGO7Ti5IFW7sFTqQiX-XC3HmWxdEjvYCaveeAdOvB5PwqBdVlvwxZbm529mPn1Z9pDRF4zy8mWKMHCZU34nO86pkLOc5_ndg_dRdprSNcUj80qw6n52lCtV5JxVx9mPlWvqaJwnS_BAPtgI4J1fk_MG_OhaB4kY8g42ZAUpGGunvjYdWXbTaHozQlw7Sy7NeLUxN8T4BuGViV8gkjZEsgiD6R3qzqHrEspMMQwxjGBHaAg2vUTW-RT8r-8_E1m4BCbBg-xea7oEp7v7JPv05vXH-dvZxfvl-fzsYmaFkuNMNQKktVWBi9Si5pWoweYNtIIqC7KltqxyUbatqKvCGsGlUMIwqJvCFCUHfpI93-qmDQxTrYfoehNvdDBOL9znMx3iWk-T5lShc4i_2uLI9tBY9Cea7tav2xXvrvQ6fNOSKlaWBQo82QnE8HWCNOreJYvOGA9hSpqVXEpaKq4QffwPeh2m6NENpKqKMSpVidTTLWVjSJiDdj8Mo_pPOPQ-HMg-Opx-T_6NAgLPdm5gya8hHrT8T-0356LHRg</recordid><startdate>20161020</startdate><enddate>20161020</enddate><creator>Viereckel, Thomas</creator><creator>Dumas, Sylvie</creator><creator>Smith-Anttila, Casey J. A.</creator><creator>Vlcek, Bianca</creator><creator>Bimpisidis, Zisis</creator><creator>Lagerström, Malin C.</creator><creator>Konradsson-Geuken, Åsa</creator><creator>Wallén-Mackenzie, Åsa</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope></search><sort><creationdate>20161020</creationdate><title>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</title><author>Viereckel, Thomas ; Dumas, Sylvie ; Smith-Anttila, Casey J. A. ; Vlcek, Bianca ; Bimpisidis, Zisis ; Lagerström, Malin C. ; Konradsson-Geuken, Åsa ; Wallén-Mackenzie, Åsa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>38/61</topic><topic>45/77</topic><topic>631/378/340</topic><topic>631/378/3920</topic><topic>64/110</topic><topic>64/60</topic><topic>9/10</topic><topic>9/74</topic><topic>Addictions</topic><topic>Amperometry</topic><topic>Animals</topic><topic>Basic Helix-Loop-Helix Transcription Factors - genetics</topic><topic>Basic Helix-Loop-Helix Transcription Factors - metabolism</topic><topic>Capsaicin receptors</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>Dopamine receptors</topic><topic>Dopaminergic Neurons - metabolism</topic><topic>Dopaminergic Neurons - pathology</topic><topic>GABAergic Neurons - metabolism</topic><topic>GABAergic Neurons - pathology</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>Gastrin-Releasing Peptide - genetics</topic><topic>Gastrin-Releasing Peptide - metabolism</topic><topic>Gene expression</topic><topic>Gene Expression Regulation</topic><topic>Genetics</topic><topic>Glutamatergic transmission</topic><topic>Glutamic Acid - metabolism</topic><topic>Heterogeneity</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Information processing</topic><topic>Mental disorders</topic><topic>Mesencephalon</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mood</topic><topic>Movement disorders</topic><topic>multidisciplinary</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Neurodegenerative diseases</topic><topic>Neurological diseases</topic><topic>Neurons</topic><topic>Optics</topic><topic>Optogenetics</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson's disease</topic><topic>Pars Compacta - metabolism</topic><topic>Pars Compacta - pathology</topic><topic>Rodents</topic><topic>Schizophrenia</topic><topic>Science</topic><topic>Subpopulations</topic><topic>Substantia nigra</topic><topic>Synaptic Transmission</topic><topic>TRPV Cation Channels - genetics</topic><topic>TRPV Cation Channels - metabolism</topic><topic>Ventral Tegmental Area - metabolism</topic><topic>Ventral Tegmental Area - pathology</topic><topic>Ventral tegmentum</topic><topic>γ-Aminobutyric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Viereckel, Thomas</creatorcontrib><creatorcontrib>Dumas, Sylvie</creatorcontrib><creatorcontrib>Smith-Anttila, Casey J. A.</creatorcontrib><creatorcontrib>Vlcek, Bianca</creatorcontrib><creatorcontrib>Bimpisidis, Zisis</creatorcontrib><creatorcontrib>Lagerström, Malin C.</creatorcontrib><creatorcontrib>Konradsson-Geuken, Åsa</creatorcontrib><creatorcontrib>Wallén-Mackenzie, Åsa</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Viereckel, Thomas</au><au>Dumas, Sylvie</au><au>Smith-Anttila, Casey J. A.</au><au>Vlcek, Bianca</au><au>Bimpisidis, Zisis</au><au>Lagerström, Malin C.</au><au>Konradsson-Geuken, Åsa</au><au>Wallén-Mackenzie, Åsa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2016-10-20</date><risdate>2016</risdate><volume>6</volume><issue>1</issue><spage>35203</spage><epage>35203</epage><pages>35203-35203</pages><artnum>35203</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>The ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) of the midbrain are associated with Parkinson’s disease (PD), schizophrenia, mood disorders and addiction. Based on the recently unraveled heterogeneity within the VTA and SNc, where glutamate, GABA and co-releasing neurons have been found to co-exist with the classical dopamine neurons, there is a compelling need for identification of gene expression patterns that represent this heterogeneity and that are of value for development of human therapies. Here, several unique gene expression patterns were identified in the mouse midbrain of which
NeuroD6
and
Grp
were expressed within different dopaminergic subpopulations of the VTA, and
TrpV1
within a small heterogeneous population. Optogenetics-coupled
in vivo
amperometry revealed a previously unknown glutamatergic mesoaccumbal pathway characterized by
TrpV1-Cre
-expression. Human GRP was strongly detected in non-melanized dopaminergic neurons within the SNc of both control and PD brains, suggesting GRP as a marker for neuroprotected neurons in PD. This study thus unravels markers for distinct subpopulations of neurons within the mouse and human midbrain, defines unique anatomical subregions within the VTA and exposes an entirely new glutamatergic pathway. Finally, both TRPV1 and GRP are implied in midbrain physiology of importance to neurological and neuropsychiatric disorders.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>27762319</pmid><doi>10.1038/srep35203</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2016-10, Vol.6 (1), p.35203-35203, Article 35203 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_swepub_primary_oai_DiVA_org_uu_307529 |
source | Open Access: PubMed Central; Publicly Available Content Database; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 38/61 45/77 631/378/340 631/378/3920 64/110 64/60 9/10 9/74 Addictions Amperometry Animals Basic Helix-Loop-Helix Transcription Factors - genetics Basic Helix-Loop-Helix Transcription Factors - metabolism Capsaicin receptors Dopamine Dopamine - metabolism Dopamine receptors Dopaminergic Neurons - metabolism Dopaminergic Neurons - pathology GABAergic Neurons - metabolism GABAergic Neurons - pathology gamma-Aminobutyric Acid - metabolism Gastrin-Releasing Peptide - genetics Gastrin-Releasing Peptide - metabolism Gene expression Gene Expression Regulation Genetics Glutamatergic transmission Glutamic Acid - metabolism Heterogeneity Humanities and Social Sciences Humans Information processing Mental disorders Mesencephalon Mice Mice, Transgenic Mood Movement disorders multidisciplinary Nerve Tissue Proteins - genetics Nerve Tissue Proteins - metabolism Neurodegenerative diseases Neurological diseases Neurons Optics Optogenetics Parkinson Disease - genetics Parkinson Disease - metabolism Parkinson Disease - pathology Parkinson's disease Pars Compacta - metabolism Pars Compacta - pathology Rodents Schizophrenia Science Subpopulations Substantia nigra Synaptic Transmission TRPV Cation Channels - genetics TRPV Cation Channels - metabolism Ventral Tegmental Area - metabolism Ventral Tegmental Area - pathology Ventral tegmentum γ-Aminobutyric acid |
title | Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A29%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Midbrain%20Gene%20Screening%20Identifies%20a%20New%20Mesoaccumbal%20Glutamatergic%20Pathway%20and%20a%20Marker%20for%20Dopamine%20Cells%20Neuroprotected%20in%20Parkinson%E2%80%99s%20Disease&rft.jtitle=Scientific%20reports&rft.au=Viereckel,%20Thomas&rft.date=2016-10-20&rft.volume=6&rft.issue=1&rft.spage=35203&rft.epage=35203&rft.pages=35203-35203&rft.artnum=35203&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep35203&rft_dat=%3Cproquest_swepu%3E1835508737%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-7d4e5cc96319b4b394bec2def407ce5f0c89248ff4b96ca435474a1ebd6a683e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1899110578&rft_id=info:pmid/27762319&rfr_iscdi=true |